Home > Insider Trading > Filing (0001209191-23-053235)

Filing Details

Accession Number:: 0001209191-23-053235
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-20 16:02:31
Reporting Period:: 2023-10-18

Accepted Time:: 2023-10-20 16:02:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1845337	Day One Biopharmaceuticals Inc.	DAWN	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1326628	Len Blavatnik	C/O Access Industries, Inc. 40 West 57Th Street, 28Th Fl New York NY 10019	No	No	No	Yes
1391297	Access Industries Holdings Llc	C/O Access Industries, Inc. 40 West 57Th Street, 28Th Fl New York NY 10019	No	No	No	Yes
1508226	Access Industries Management, Llc	C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019	No	No	No	Yes
1863302	Ai Day1 Llc	C/O Access Industries, Inc. 40 West 57Th Street, 28Th Floor New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-10-18	979,667	$10.21	12,433,535	No	4	P	Direct
Common Stock	Acquisiton	2023-10-19	384,400	$10.06	12,817,935	No	4	P	Direct
Common Stock	Acquisiton	2023-10-20	111,387	$9.97	12,929,322	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $10.07 to $10.29 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The securities reported are held directly by AI Day1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $9.88 to $10.20 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average purchase price of the shares of common stock. The shares of common stock were purchased in multiple transactions ranging from $9.83 to $10.13 inclusive. The reporting persons undertake to provide to Day One Biopharmaceuticals, Inc., any security holder of Day One Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the ranges set forth in this footnote to this Form 4.